Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Peine – page 2

22 clinical trials in Peine, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Peine at a glance
22
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

22 trials in Peine

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Peine

What the registry says about research in the country

01 Respiratory Disease Management

Comprehensive research focusing on Chronic Obstructive Pulmonary Disease (COPD) treatments, including studies evaluating triple therapy combinations and novel biologics for reducing exacerbations.

  • Triple therapy effectiveness
  • Exacerbation reduction strategies
  • Cardiopulmonary outcomes

Innovative approaches exploring gene expression in former and current smokers with COPD.

02 Asthma Research

Advanced studies examining uncontrolled asthma treatments, focusing on new therapeutic options for patients with moderate-to-severe conditions not adequately managed with current medications.

  • Maintenance therapy optimization
  • Novel rescue medications
  • Airway inflammation control

Investigations into gene expression patterns and innovative treatment approaches for better asthma control.

03 Allergy Studies

Comprehensive research on allergic rhinitis and rhinoconjunctivitis, including trials for both seasonal and perennial allergies triggered by various environmental factors.

  • Immunotherapy development
  • Grass pollen allergies
  • House dust mite treatments

Specialized focus on developing long-term solutions for both pediatric and adult populations affected by allergies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.